Skip to main content
Bioton S.A. logo

Bioton S.A. — Investor Relations & Filings

Ticker · BIO ISIN · PLBIOTN00029 LEI · 259400I5R1L3OPCGII81 WAR Manufacturing
Open in API
Filings indexed 697 across all filing types
Latest filing 2023-05-23 Audit Report / Informat…
Country PL Poland
Listing WAR BIO

About Bioton S.A.

https://bioton.com/en/

Bioton S.A. is a biotechnology company focused on providing comprehensive solutions for diabetes care. The company's core activity is the development and production of recombinant human insulin, positioning it as a significant commercial manufacturer globally. Its operations cover the full biotechnological process, from DNA research and development to the manufacturing and marketing of finished medicinal products. The product portfolio is centered on various forms of insulin and is complemented by modern automatic injection systems designed to facilitate effective diabetes treatment for patients.

Recent filings

Filing Released Lang Actions
Ocena Rady Nadzorczej sprawozdań finansowych
Audit Report / Information Classification · 95% confidence The document is titled 'OCENA ROCZNYCH SPRAWOZDAŃ FINANSOWYCH I ROCZNYCH SPRAWOZDAŃ Z DZIAŁALNOŚCI DOKONANA PRZEZ RADĘ NADZORCZĄ BIOTON S.A.' (Assessment of Annual Financial Statements and Annual Report on the Operations worked by the Supervisory Board of BIOTON S.A.). It details the Supervisory Board's review and assessment of the financial statements and management reports for the financial year ended December 31, 2022. It explicitly mentions reviewing the balance sheet, profit and loss account, cash flow statement, and the management board's report on operations, which are core components of the Annual Report (10-K) process. However, this specific document is the *Supervisory Board's assessment* of those reports, not the full financial statements or the management report itself. In many jurisdictions, the formal review and approval of the annual accounts by the Supervisory Board often results in a specific filing that summarizes this review, which is closely related to the Audit Report/Information (AR) or Governance Information (CGR). Given that it focuses heavily on the assessment of the financial statements and the auditor's opinion regarding those statements, it aligns best with the scope of an Audit Report/Information (AR) or a document detailing the results of internal/regulatory review processes, rather than the full 10-K or a simple announcement (RPA). Since it contains detailed financial figures and the auditor's conclusion on the fairness of the statements, AR is the most appropriate fit among the provided options, as it covers 'applied accounting principles, and results of internal or regulatory stress tests (excluding full Annual Reports)'. FY 2022
2023-05-23 Polish
Korekta raportu okresowego oraz skonsolidowanego raportu okresowego za rok 2022 - Content (PL)
Report Publication Announcement Classification · 99% confidence The document text, written in Polish, announces that the annual report ('raport roczny') and consolidated annual report for 2022 of Bioton S.A. have been supplemented ('został uzupełniony') with the Supervisory Board's assessment of the activity reports and financial statements. It explicitly states that the financial information published on March 31, 2023, remains unchanged. This is an announcement about an update/supplement to an already published annual report, rather than the full annual report (10-K) itself. Given the short length (720 chars) and the nature of announcing a supplement/attachment to a main report, it fits best under a general regulatory announcement category. Since there is no specific category for 'Annual Report Supplement Announcement', and it is a formal regulatory disclosure based on Polish Ministry of Finance regulations, the most appropriate fallback is Regulatory Filings (RNS). It is not an Earnings Release (ER) as it refers to the final annual report, nor is it a Report Publication Announcement (RPA) as it is an amendment/supplement, not the initial publication announcement.
2023-05-23 Polish
Raport biegłego z oceny sprawozdania o wynagrodzeniach
Audit Report / Information Classification · 98% confidence The document is titled "RAPORT NIEZALEŻNEGO BIEGŁEGO REWIDENTA" (Independent Auditor's Report) and explicitly states it is an assessment of the attached "sprawozdanie o wynagrodzeniach" (remuneration report) for Bioton Spółka Akcyjna for the year 2022, referencing specific Polish public offering laws (art. 90g). This document is the formal report issued by an external auditor regarding the completeness of the remuneration report. The definition for Remuneration Information (DEF 14A) covers compensation reports for top executives and directors. Since this document is the *Audit Report* specifically on the remuneration report, it aligns most closely with the Audit Report / Information category (AR), which covers standalone audit reports, rather than the remuneration report itself (DEF 14A) or a general Annual Report (10-K). The content is a formal attestation service report based on KSUA 3000 (Z). FY 2022
2023-05-22 Polish
Sprawozdanie Rady Nadzorczej o wynagrodzeniach za 2022
Remuneration Information Classification · 99% confidence The document is titled "SPRAWOZDANIE RADY NADZORCZEJ BIOTON S.A. o wynagrodzeniach Członków Zarządu oraz Rady Nadzorczej za rok 2022" (Report of the Supervisory Board of BIOTON S.A. on the remuneration of Management Board and Supervisory Board Members for the year 2022). It details the remuneration structure, components (fixed, variable, benefits), performance criteria, and comparisons for the Management Board members for the year 2022. This content directly aligns with the definition of a report detailing compensation for top executives and directors, which corresponds to the 'Remuneration Information' category. Specifically, the document structure and content match the requirements outlined in the definition for DEF 14A (Proxy Solicitation & Information Statement often contains remuneration details, but the specific focus here is remuneration disclosure, which is often covered by specific regulations leading to a DEF 14A equivalent or similar disclosure). Reviewing the provided definitions: - DEF 14A: Remuneration Information (Report detailing compensation for top executives and directors). This document is a detailed report on remuneration, not just an announcement of a report (RPA/RNS), and its length (49,380 chars) confirms it is the report itself. Therefore, the most appropriate classification is DEF 14A.
2023-05-22 Polish
Sprawozdanie Rady Nadzorczej za 2022
AGM Information Classification · 98% confidence The document is titled "SPRAWOZDANIE RADY NADZORCZEJ BIOTON S.A. ZA ROK 2022" which translates to "REPORT OF THE SUPERVISORY BOARD OF BIOTON S.A. FOR THE YEAR 2022". This report details the Supervisory Board's activities, assessment of management reports and financial statements for the year 2022, governance practices, and includes recommendations for the General Meeting. This content strongly aligns with the scope of an Audit Report / Information (AR), as it involves the Supervisory Board's assessment of the annual financial statements and internal controls, although it is a specific type of board report rather than a pure external auditor's report. However, given the options, 'AR' (Audit Report / Information) is the closest fit for a comprehensive report detailing the board's review of the annual results and controls, especially since '10-K' is reserved for the full Annual Report itself, and this is the Supervisory Board's specific report on that process. It is not a general regulatory filing (RNS) because it is a specific, named report type.
2023-05-22 Polish
Ogłoszenie ZWZ
AGM Information Classification · 100% confidence The document is explicitly titled "OGŁOSZENIE ZARZĄDU BIOTON SPÓŁKI AKCYJNEJ O ZWOŁANIU ZWYCZAJNEGO WALNEGO ZGROMADZENIA BIOTON S.A." (Announcement of the Management Board of BIOTON S.A. on the convening of the Annual General Meeting of BIOTON S.A.). It details the date, time, location, and the full agenda (Porządek obrad) for the meeting, including items related to approving the 2022 financial statements and granting discharge (absolutorium). This content directly corresponds to the definition of materials shared during an Annual General Meeting (AGM). Therefore, the appropriate classification is AGM-R.
2023-05-22 Polish

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.